Skip to main content

Table 1 Clinical characteristics

From: Eukaryotic Initiation Factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer

Variable No. of patients (%)
Total 122 (100%)
Age (median, 56 years)  
   <56 years 68 (55.7%)
   ≥56 years 54 (44.3%)
Surgical treatment  
   Breast conservation 29 (23.8%)
   Mastectomy 93 (76.2%)
Tumor size (mean, 3.1 cm)  
   <3.1 cm 70 (57.4%)
   ≥3.1 cm 52 (42.6%)
Histological diagnosis  
   Invasive carcinoma 102 (83.6%)
Ductal 80 (65.6%)
Lobular 14 (11.5%)
Medullary 6 (4.9%)
Tubular 2 (1.6%)
   Non invasive carcinoma 20 (16.4%)
DCIS 15 (12.3%)
LCIS 5 (4.1%)
Histological grade  
   Invasive carcinoma 102 (83.6%)
Grade I 27 (22.1%)
Grade II 41 (33.6%)
Grade III 34 (27.9%)
   Non invasive carcinoma 20 (16.4%)
Low grade 5 (4.1%)
Intermediate grade 3 (2.5%)
High grade 12 (9.8%)
TNM staging  
   Stage I 30 (24.6%)
   Stage II 33 (27.1%)
   Stage III 37 (30.3%)
   Stage IV 22 (18.0%)
Node metastatic status  
   Negative 48 (39.3%)
   Positive 74 (60.7%)
Estrogen Receptor status  
   Negative 54 (44.3%)
   Positive 68 (55.7%)
Progesterone Receptor status  
   Negative 65 (53.3%)
   Positive 57 (46.7%)
Her-2/neu status  
   Negative 66 (54.1%)
   Positive 56 (45.9%)
Clinical outcome  
   Disease free 77 (63.1%)
   Metastasis or recurrence 45 (36.9%)
   Died for breast cancer 30 (24.6%)